UPR vs. UDG, MDC, BTG, ABC, HCM, INDV, GNS, ONT, CLIN, and EMIS
Should you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Mediclinic International (MDC), BTG (BTG), Abcam (ABC), HUTCHMED (HCM), Indivior (INDV), Genus (GNS), Oxford Nanopore Technologies (ONT), Clinigen Group (CLIN), and EMIS Group (EMIS). These companies are all part of the "medical" sector.
Uniphar vs. Its Competitors
Uniphar (LON:UPR) and UDG Healthcare (LON:UDG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.
Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 0.6%. UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays out 13.9% of its earnings in the form of a dividend. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.
Uniphar presently has a consensus price target of GBX 310, indicating a potential downside of 0.32%. Given UDG Healthcare's higher possible upside, analysts plainly believe UDG Healthcare is more favorable than Uniphar.
45.3% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Uniphar has a net margin of 1.68% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.18% beat UDG Healthcare's return on equity.
In the previous week, Uniphar had 1 more articles in the media than UDG Healthcare. MarketBeat recorded 1 mentions for Uniphar and 0 mentions for UDG Healthcare. Uniphar's average media sentiment score of 0.59 beat UDG Healthcare's score of 0.00 indicating that Uniphar is being referred to more favorably in the media.
Summary
Uniphar beats UDG Healthcare on 11 of the 15 factors compared between the two stocks.
Get Uniphar News Delivered to You Automatically
Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding UPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:UPR) was last updated on 7/18/2025 by MarketBeat.com Staff
